Swot Analysis : Pfizer'swot

1262 Words6 Pages
3. ANALYSIS The report will now apply the concepts discussed in the previous section to the specific case of Pfizer. The analysis will help to determine whether this company has achieved a competitive advantage. 3.1. SWOT analysis Pfizer’ SWOT analysis is summarized in two tables. Table 1 focuses on the external analysis. Table 2 is devoted to the internal analysis. Table 1 Pfizer’ external analysis Opportunities Threats Industry environment: - Threat of entry: The threat of entry is low because potential competitors face high entry barriers such substantial investments in research and development (R&D) - Focus on biologics: Pfizer will have the opportunity to develop new drugs, get into this market area Industry environment: - Exposure to generic drugs: The population reaching for generic drugs as cheap alternatives to prescription medication - Bargaining power of buyers: Pfizer will have to take on retailers such as Target and Walmart, which already have discount programs in place for their customers General environment: - Demographics: The elderly will need medication, Pfizer has the opportunity to strengthen its position by catering to this specific group of customers - Product approval: In the past, several new products have been approved that will greatly enhance Pfizer’s portfolio General environment: - Global pricing pressure: In most countries the government controls the prices, this could negatively influence Pfizer’s sales and revenue - FDA’s regulatory
Open Document